Literature DB >> 15928502

Lymphocytes in pleural disease.

Nicola Dalbeth1, Y C Gary Lee.   

Abstract

PURPOSE OF REVIEW: Lymphocytic pleural effusions are characterised by divergent cellular responses depending on the etiology of disease. The pathogenic role of lymphocytes in pleural disease, however, remains unclear. This review provides a basic description of the functions of the different lymphocyte subsets within the pleural space and then summarises recent studies of lymphocyte biology in pleural disease. RECENT
FINDINGS: The mechanisms of lymphocyte trafficking into the pleural space have been clarified. Specific adhesion molecules (such as intercellular adhesion molecule-1 and vascular cell adhesion molecule-1) and chemokines (CXCL13, interleukin-8, and monocyte chemotactic protein-1) have been identified as important factors involved in the accumulation of lymphocytes during inflammatory pleuritis. Both cellular and soluble factors may contribute to impaired T-cell immunity in malignant pleural effusions. Studies of natural killer cell and gammadelta T-cell biology indicate that these lymphocyte subsets may also play a role in the pathogenesis of pleural disease. The dominant Th1 response characterised by tuberculous pleuritis may allow for rapid diagnosis of disease. Furthermore, strategies for improving cytotoxic T-cell and natural killer cell function show promise for treatment of malignant pleural disease.
SUMMARY: Recent work has provided insight into the pathogenesis of disease in lymphocytic pleural effusions. Further study of specific cellular responses may offer significant opportunities in the diagnosis and management of these disorders.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15928502     DOI: 10.1097/01.mcp.0000166490.92659.17

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  8 in total

1.  Imbalance of Th17 cells and regulatory T cells in tuberculous pleural effusion.

Authors:  Zhi-Jian Ye; Qiong Zhou; Rong-Hui Du; Xiao Li; Bo Huang; Huan-Zhong Shi
Journal:  Clin Vaccine Immunol       Date:  2011-08-03

2.  Th17/Treg imbalance in malignant pleural effusion.

Authors:  Wei-Bing Yang; Zhi-Jian Ye; Fei Xiang; Jian-Chu Zhang; Qiong Zhou
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-02-08

3.  Increased pleural fluid adenosine deaminase levels in patients with malignant pleural effusions: a potential predictor of talc pleurodesis outcome.

Authors:  Huseyin Yildirim; Muzaffer Metintas; Güntülü Ak; Sinan Erginel; Fusun Alatas; Emel Kurt; Selma Metintas; Irfan Ucgun
Journal:  Lung       Date:  2007-10-19       Impact factor: 2.584

4.  Kinetics of host cell recruitment during dissemination of diffuse malignant peritoneal mesothelioma.

Authors:  Nathan R Miselis; Bonnie W Lau; Zhijin Wu; Agnes B Kane
Journal:  Cancer Microenviron       Date:  2010-06-22

5.  Analysis of Lymphocyte Immunological Reactivity in Patients with Pleural Effusions of Different Aetiology.

Authors:  Zlatica Goseva; Biserka Jovkovska Kaeva; Angelko Gjorcev; Elena Jovanovska Janeva; Zoran Arsovski; Sava Pejkovska; Aleksandra Tatabitovska
Journal:  Open Access Maced J Med Sci       Date:  2015-12-25

6.  Pleural tuberculosis: medical thoracoscopy greatly increases the diagnostic accuracy.

Authors:  Angelo Gianni Casalini; Pier Anselmo Mori; Maria Majori; Miriam Anghinolfi; Enrico Maria Silini; Letizia Gnetti; Federica Motta; Sandra Larini; Sara Montecchini; Roberta Pisi; Adriana Calderaro
Journal:  ERJ Open Res       Date:  2018-01-05

7.  An undiagnosed pleural effusion with surprising consequences.

Authors:  A G Casalini; F Cusmano; N Sverzellati; P A Mori; M Majori
Journal:  Respir Med Case Rep       Date:  2017-05-26

8.  Plasma endothelial protein C receptor influences innate immune response in ovarian cancer by decreasing the population of natural killer and TH17 helper cells.

Authors:  Dalel Azzazene; Hamda Al Thawadi; Halema Al Farsi; Samaher Besbes; Caroline Geyl; Shahsoltan Mirshahi; Julia Pardo; Anne Marie Faussat; Soria Jeannette; Amu Therwath; Eric Pujade-Lauraine; Massoud Mirshahi
Journal:  Int J Oncol       Date:  2013-07-18       Impact factor: 5.650

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.